Immunocellular OTC Stock Performance

The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. Let's try to break down what Immunocellular's beta means in this case. the returns on MARKET and Immunocellular Therapeutics are completely uncorrelated. Although it is extremely important to respect Immunocellular Therapeutics current price history, it is better to be realistic regarding the information on equity current price movements. The philosophy towards determining future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By evaluating Immunocellular Therapeutics technical indicators, you can presently evaluate if the expected return of 0.0% will be sustainable into the future. Immunocellular Therapeutics right now retains a risk of 0.0%. Please check out Immunocellular Therapeutics jensen alpha, as well as the relationship between the potential upside and skewness to decide if Immunocellular Therapeutics will be following its current trending patterns.

Immunocellular O TC Stock Performance 

Immunocellular Performance
0 of 100
Over the last 90 days Immunocellular Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Immunocellular Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Quick Ratio8.31
Fifty Two Week Low0.0590
Fifty Two Week High0.9800

Immunocellular Therapeutics Relative Risk vs. Return Landscape

If you would invest (100.00)  in Immunocellular Therapeutics on July 30, 2021 and sell it today you would earn a total of  100.00  from holding Immunocellular Therapeutics or generate -100.0% return on investment over 90 days. Immunocellular Therapeutics is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of otc stocks are less volatile than Immunocellular, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
 Daily Expected Return (%) 
      Risk (%) 

Immunocellular Therapeutics Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Immunocellular Therapeutics' investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Immunocellular Therapeutics, and traders can use it to determine the average amount a Immunocellular Therapeutics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Good Returns
Average Returns
Small Returns
Based on monthly moving average Immunocellular Therapeutics is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immunocellular Therapeutics by adding it to a well-diversified portfolio.

Things to note about Immunocellular Therapeutics

Checking the ongoing alerts about Immunocellular Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Immunocellular Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Immunocellular Therapeutics Alerts

Equity Alerts and Improvement Suggestions

Immunocellular Therapeutics is not yet fully synchronised with the market data
Immunocellular Therapeutics has some characteristics of a very speculative penny stock
Immunocellular Therapeutics has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 300 K. Net Loss for the year was (9.03 M) with profit before overhead, payroll, taxes, and interest of 0.
Immunocellular Therapeutics currently holds about 2.85 M in cash with (10.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.68.
Check out Risk vs Return Analysis. Note that the Immunocellular Therapeutics information on this page should be used as a complementary analysis to other Immunocellular Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Tools for Immunocellular OTC Stock

When running Immunocellular Therapeutics price analysis, check to measure Immunocellular Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunocellular Therapeutics is operating at the current time. Most of Immunocellular Therapeutics' value examination focuses on studying past and present price action to predict the probability of Immunocellular Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunocellular Therapeutics' price. Additionally, you may evaluate how the addition of Immunocellular Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Bond Directory
Find actively traded corporate debentures issued by US companies
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk